Page 1

Note : This document has been translated from the Japanese original for reference purposes only . In the event of any discrepancy between this translated document and the Japanese original , the original shall prevail . Consolidated Financial Results for the Three Months Ended August 31 , 2026 ( Under Japanese GAAP ) Company name : COSMOS Pharmaceutical Corporation Listing : Tokyo Stock Exchange Securities code : 3349 October 13 , 2026 Accounting Financial Ad as Foundation Standards F FASF MEMBERSHIP URL : https://www.cosmospc.co.jp Representative : Hideaki Yokoyama President Inquiries : Motoi Takemori Director and Corporate Planning Department Manager Telephone : + 81-92-433-0660 Preparation of supplementary material on financial results : None Scheduled date to commence dividend payments : - Holding of financial results briefing : Yes ( for analysts and institutional investors ) ( Yen amounts are rounded down to millions , unless otherwise noted . ) 1. Consolidated financial results for the three months ended August 31 , 2026 ( from June 1 , 2026 to August 31 , 2026 ) ( 1 ) Consolidated operating results ( cumulative ) ( Percentages indicate year - on - year changes . ) Net sales Millions of EBITDA Millions of Operating profit Ordinary profit Profit attributable to owners of parent Millions of Millions of Millions of Three months ended yen August 31 , 2026 286,653 % 5.2 August 31 , 2025 272,394 4.0 yen 17,911 16,947 % yen % yen % yen % 5.7 3.6 12,005 11,645 3.1 12,766 4.7 8,251 1.0 0.6 12,188 ( 0.9 ) 8,171 0.3 Note : Comprehensive income For the three months ended August 31 , 2026 : For the three months ended August 31 , 2025 : ¥ 8,241 million [ 0.9 % ] ¥ 8,167 million [ 0.3 % ] Three months ended August 31 , 2026 Basic earnings per share Yen 104.11 103.10 Diluted earnings per share Yen August 31 , 2025 ( 2 ) Consolidated financial position As of August 31 , 2026 May 31 , 2026 Total assets Net assets Equity - to - asset ratio Millions of yen Millions of yen % 590,563 288,414 48.8 596,485 283,700 47.6 As of August 31 , 2026 : ¥ 288,414 million As of May 31 , 2026 : ¥ 283,700 million Reference : Equity